Pills

More than 1 million Medicare beneficiaries had a diagnosis of opioid use disorder in 2020.1 However, fewer than 1 in 5 Medicare beneficiaries with an opioid use disorder (OUD) diagnosis received medication to treat this condition. In addition, the number of patients who stay in treatment after hospital discharge decrease drastically during the transition of care.2

Join us for the next session of the QIN-QIO Collaborative Opioid Series, Sustaining Recovery for Patients on Medications for Opioid Use Disorder (MOUD), on Friday, April 12, 2024. In this webinar, our guest speakers will describe how they support people in recovery beyond the walls of the hospital, nursing homes, and Opioid Treatment Programs (OTPs). We will learn more about the specific strategies that can be implemented in rural communities and discuss how to coordinate and sustain this support with your community partners.

This webinar series is a collaboration of all of the Quality Innovation Network-Quality Improvement Organizations and will provide strategies, interventions, and targeted solutions to ensure access to MOUD treatment and facilitate the continuity of care through the continuum. This series’ focus is ensuring MOUD treatment within nursing home/hospital care transitions, but is appropriate for all care settings, including nursing homes, clinics and hospital care teams and their partners.

pill bottles

Register Today

 

A general certificate of attendance will be provided for continuing education/contact hours. Attendees are responsible for determining if this program meets the criteria for licensure or recertification for their discipline.

 

Next Session: Sustaining Recovery for Patients on MOUD

Session 8 (Part 2: Panel Discussion)—May 10, 2024

Panel Discussion: Sustaining Recovery for Patients on MOUD
Alternatives to Opioids (ALTO), peer support, NA meetings, counseling, and use of technologies

In this webinar, our guest speakers described how they support people in recovery beyond the walls of the hospital, nursing homes, and Opioid Treatment Programs (OTPs). Attendees learned more about the specific strategies that can be implemented in rural communities and how to coordinate and sustain this support with community partners.

On May 10, 2024, a panel discussion will take place in follow up to the April 12 presentation.

 

Upcoming Session

Session 9—June 7, 2024

Management of Patients on MOUD: Key Takeaways and Series Wrap Up
Join us to hear the key takeaways of this series of webinars.

 


Past Sessions

PAST EVENT | Session 1 - Role of the Emergency Department (ED) Physician in the Treatment of Patients with OUD

Basics & science of addiction and screening & initiating MOUD

Emergency Physicians are active participants in the quest of solutions to identify patients at risk for substance abuse while using reasonable prescribing guidelines to address the legitimate pain reliefs needs of their patients.
Learn how to recognize opioid use disorder, identify withdrawal, and initiate MOUD in the ED.

Speaker: Bobby Redwood, MD, MPH, FACEP

PAST EVENT | Session 2 - Role of the Pharmacist in the Treatment of Patients with OUD

Medication processes, addressing opioid adverse drug events (ADEs), and risk assessment for opioid prescribing.

Speakers:
Kyla Newland, PharmD:
Clinical Pharmacist and Account Manager with Mountain Pacific Quality Health
Megan Penner, PharmD, BCPS: Clinical Assistant Professor, L.S. Skaggs College of Pharmacy
Clinical Pharmacist, Mat Su Regional Medical Center
Jon Pouliot, MS, PharmD, BCPS: Associate Professor, Pharmacy and Pharmaceutical Sciences, Lipscomb University
Emergency Medicine Pharmacist, Williamson Medical Center

PAST EVENT | Session 3 - Seamlessly Transitioning Patients on MOUD to Nursing Homes

During this 2-part webinar, you will learn more from key actors that prepare the patient for discharge and communicate effectively with the receiving facility.

Session 3; Part 1: Presentation

PAST EVENT | Session 4 - Seamlessly Transitioning Patients on MOUD to Nursing Homes

Session 4; Part 2: Panel Discussion

A well-planned transition of care ensures health care continuity, avoids preventable poor outcomes among patients with OUD, and co-occurring mental health disorders. Challenges and barriers persist especially during the transfer of patients to nursing homes.

PAST EVENT | Session 5 - Management of Patients on MOUD During the Nursing Home Stay

    • Dr. Jean Storm, DO, CHCQM, Medical Director, Quality Insights
    • Rob Accetta, RPh, BCGP, FASCP, Senior Pharmacist, IPRO
    • Debra Wright, RN, BSN, RAC-CT, Quality Improvement Specialist, Quality Insights

PAST EVENT | Session 6 - Management of Patients on MOUD During the Nursing Home Stay

Management of Patients on MOUD During the Nursing Home Stay
Admissions assessment & treatment, addressing stigma, and naloxone training.

Speakers:

  • Dr. Jean Storm, DO, CHCQM, Medical Director, Quality Insights
  • Jacki Ulishney, PharmD, MHSA, BCPS, Case Management Pharmacist, Mountain Pacific
  • Amy Lund Stone, BSN, RN, Project Manager, CA Bridge
  • Jennifer Peerbolte, MPA, RN, Program Specialist, Telligen QI Connect
  • Debra Wright, RN, BSN, RAC-CT, Quality Improvement Specialist, Quality Insights

On March 10, all QIO partners hosted the sixth session of this series which consists of supporting healthcare providers to ensure MOUD Treatment Through the Care Continuum. During this session, national experts discussed how to successfully implement and/or sustain medication for opioid use disorder during a nursing home stay. They highlighted the importance of providing training on stigma reduction and having naloxone readily available in case of overdose.

    1. Massachusetts Department of Public Health – The Care of Residents with Opioid & Stimulant Use Disorders in Long-Term Care Settings toolkit

PAST EVENT | Session 7 - Sustaining Recovery for Patients on MOUD

Sustaining Recovery for Patients on MOUD

Presentation April 12, 2024 | Past Event

Speakers

  • Dr. Ryan Sarver, MD, FAAFP, Adjunct Assistant Professor of Clinical Medicine for Indiana University School of Medicine
  • Heather Brandt, Manager, North Dakota Behavioral Health Community Supports
  • Jake Reuter, North Dakota Health and Human Services, Administrator
  • Lindsay Sarver, Community Health Improvement Strategist

Access the PowerPoint 
Access the Event Recording

In this webinar, our guest speakers described how they support people in recovery beyond the walls of the hospital, nursing homes, and Opioid Treatment Programs (OTPs). Attendees learned more about the specific strategies that can be implemented in rural communities and how to coordinate and sustain this support with community partners.

 

Questions? Contact: Tammy Wagner, RN, LSSGB; Great Plains Quality Innovation Network Quality Improvement Advisor, at tammy.wagner@greatplainsqin.org


References:
1 Health and Human Services: Office of Inspector General. Combating the Opioid Epidemic OIG Report. May 18, 2023. Accessed on: August 2, 2023. Available at: https://oig.hhs.gov/reports-and-publications/featured-topics/opioids/
2 Klimas J, Hamilton M, et al. Retention in Opioid Agonist Treatment: A Rapid Review and Meta-Analysis Comparing Observational Studies and Randomized Controlled Trials. August 6, 2021. Available at: https://systematicreviewsjournal.biomedcentral.com/articles/10.1186/s13643-021-01764-9